{"entity":{"id":"regulatory-t-cells","kind":"term","name":"Regulatory T cells","aka":["Treg","Tregs","regulatory T cell"],"tldr":"Some T cells restrain immune responses and help protect healthy tissues. Their presence alone does not measure suppression.","summary":"Regulatory T cells help maintain self-tolerance and can restrain antitumour responses. Mouse experiments established a regulatory role for CD4/CD25 populations and linked Foxp3 to the regulatory programme. CTLA-4 can remove CD80/CD86 from antigen-presenting cells, reducing support available to other T cells. This is one mechanism, rather than a complete account of every regulatory population.\n\nIn defined human cultures, induced FOXP3 expression did not confer suppressive function. Human colorectal cancers also contained functionally distinct FOXP3-positive populations. FOXP3 staining alone therefore does not establish suppression or a universal prognosis; CD25 also needs identity and activation context. Use a defined marker panel, tissue location and controlled suppression assays. Mixed RNA signatures do not locate every contributing cell. Regulatory cells are not exhausted effectors, and removing restraint does not automatically provide safe clinical benefit.","asOf":"2026-11-09","links":[{"label":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.","url":"https://pubmed.ncbi.nlm.nih.gov/7636184/"},{"label":"Control of regulatory T cell development by the transcription factor Foxp3.","url":"https://pubmed.ncbi.nlm.nih.gov/12522256/"},{"label":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.","url":"https://pubmed.ncbi.nlm.nih.gov/21474713/"},{"label":"Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype.","url":"https://pubmed.ncbi.nlm.nih.gov/17644734/"},{"label":"Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.","url":"https://pubmed.ncbi.nlm.nih.gov/27111280/"}],"tags":[],"related":["t-cell"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Regulatory T cells are living, context-dependent populations, commonly within CD4, that protect tolerance and may restrain useful antitumour responses. They can develop through thymic or peripheral routes. They are not exhausted effectors. Removing restraint can damage healthy tissue; cell abundance is not a universal prognostic or treatment rule.","Regulatory mechanisms include CTLA-4-mediated loss of supporting ligands and context-dependent cytokine and growth-signal interactions, including IL-2. Counting cells does not measure suppression. Flow cytometry combines markers, multiplex tissue imaging adds location and a controlled suppression assay measures a specified responder endpoint. Preserve specimen, marker and comparator definitions; bulk RNA cannot assign every cell a location or function, and none of these methods supplies a universal clinical cutoff.","Source scope: teaching synthesis checked against the cited abstracts and specified accessible primary text on 9 November 2026; fictional examples are not clinical observations or treatment-selection rules."],"category":"Immunology"},"route":"/terms/regulatory-t-cells/","neighbours":{"term":[{"id":"cd4-t-cell-subsets","kind":"term","name":"CD4 T-cell subsets","route":"/terms/cd4-t-cell-subsets/"},{"id":"t-cell","kind":"term","name":"T cell","route":"/terms/t-cell/"}],"target":[{"id":"foxp3","kind":"target","name":"FOXP3","route":"/targets/foxp3/"}]}}